日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

SARS-CoV-2 mRNA疫苗可增强肿瘤对免疫检查点阻断疗法的敏感性

Adam J Grippin #,Christiano Marconi #,Sage Copling #,Nan Li #,Chen Braun,Cole Woody,Elliana Young,Priti Gupta,Min Wang,Annette Wu,Seong Dong Jeong,Dhruvkumar Soni,Frances Weidert,Chao Xie,Eden Goldenberg,Andrew Kim,Chong Zhao,Anna DeVries,Paul Castillo,Rishabh Lohray,Michael K Rooney,Benjamin R Schrank,Yifan Wang,Yifan Ma,Enoch Chang,Ramez Kouzy,Kyle Dyson,Jordan Jafarnia,Nina Nariman,Gregory Gladish,Jacob New,Ada Argueta,Diana Amaya,Nagheme Thomas,Andria Doty,Joe Chen,Nikhil Copling,Gabriel Alatrash,Julie Simon,Alicia Bea Davies,William Dennis,Richard Liang,Jeff Lewis,Xiong Wei,Waree Rinsurongkawong,Ara A Vaporciyan,Andrew Johns  ; DCODE Team; Jack Lee,Ji-Hyun Lee,Ryan Sun,Padmanee Sharma ,Hai Tran,Jianjun Zhang,Don L Gibbons,Jennifer Wargo,Betty Y S Kim,John V Heymach,Hector R Mendez-Gomez,Wen Jiang,Elias J Sayour,Steven H Lin

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

SARS-CoV-2 mRNA疫苗可增强肿瘤对免疫检查点阻断疗法的敏感性

Adam J Grippin # ,Christiano Marconi # ,Sage Copling # ,Nan Li # ,Chen Braun ,Cole Woody ,Elliana Young ,Priti Gupta ,Min Wang ,Annette Wu ,Seong Dong Jeong ,Dhruvkumar Soni ,Frances Weidert ,Chao Xie ,Eden Goldenberg ,Andrew Kim ,Chong Zhao ,Anna DeVries ,Paul Castillo ,Rishabh Lohray ,Michael K Rooney ,Benjamin R Schrank ,Yifan Wang ,Yifan Ma ,Enoch Chang ,Ramez Kouzy ,Kyle Dyson ,Jordan Jafarnia ,Nina Nariman ,Gregory Gladish ,Jacob New ,Ada Argueta ,Diana Amaya ,Nagheme Thomas ,Andria Doty ,Joe Chen ,Nikhil Copling ,Gabriel Alatrash ,Julie Simon ,Alicia Bea Davies ,William Dennis ,Richard Liang ,Jeff Lewis ,Xiong Wei ,Waree Rinsurongkawong ,Ara A Vaporciyan ,Andrew Johns ,Ji-Hyun Lee ,Ryan Sun ,Padmanee Sharma ,Hai Tran ,Jianjun Zhang ,Don L Gibbons ,Jennifer Wargo ,Betty Y S Kim ,John V Heymach ,Hector R Mendez-Gomez ,Wen Jiang ,Elias J Sayour ,Steven H Lin

Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy

癌症引起的神经损伤会促进对PD-1抑制剂的耐药性

Erez N Baruch # ,Frederico O Gleber-Netto # ,Priyadharsini Nagarajan # ,Xiayu Rao # ,Shamima Akhter # ,Tuany Eichwald # ,Tongxin Xie ,Mohammad Balood ,Adebayo Adewale ,Shorook Naara ,Hinduja N Sathishkumar ,Shajedul Islam ,William McCarthy ,Brandi J Mattson ,Renata Ferrarotto ,Michael K Wong ,Michael A Davies ,Sonali Jindal ,Sreyashi Basu ,Karine Roversi ,Amin Reza Nikpoor ,Maryam Ahmadi ,Ali Ahmadi ,Catherine Harwood ,Irene Leigh ,Dennis Gong ,Paulino Tallón de Lara ,Derrick L Tao ,Tara M Davidson ,Nadim J Ajami ,Andrew Futreal ,Kunal Rai ,Veena Kochat ,Micah Castillo ,Preethi Gunaratne ,Ryan P Goepfert ,Sharia D Hernandez ,Nikhil I Khushalani ,Jing Wang ,Stephanie S Watowich ,George A Calin ,Michael R Migden ,Mona Yuan ,Naijiang Liu ,Yi Ye ,William L Hwang ,Paola D Vermeer ,Nisha J D'Silva ,Yuri L Bunimovich ,Dan Yaniv ,Jared K Burks ,Javier Gomez ,Patrick M Dougherty ,Kenneth Y Tsai ,James P Allison ,Padmanee Sharma ,Jennifer A Wargo ,Jeffrey N Myers ,Sebastien Talbot ,Neil D Gross ,Moran Amit

Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti-PD-1 therapy

肿瘤细胞中PTDSS1的缺失可提高免疫原性和对PD-1抗体疗法的反应。

Jielin Liu ,Shelley Herbrich,Sreyashi Basu,Yulong Chen,Ashwat Nagarajan,Swetha Anandhan,Sangeeta Goswami ,Liangwen Xiong,Baoxiang Guan,Padmanee Sharma

Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti-PD-1 therapy

肿瘤细胞中PTDSS1的缺失可提高免疫原性和对PD-1抗体疗法的反应。

Jielin Liu ,Shelley Herbrich ,Sreyashi Basu ,Yulong Chen ,Ashwat Nagarajan ,Swetha Anandhan ,Sangeeta Goswami ,Liangwen Xiong ,Baoxiang Guan ,Padmanee Sharma

TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer

TSG-6+癌相关成纤维细胞调节髓系细胞反应,并削弱胰腺癌对免疫检查点疗法的抗肿瘤反应

Swetha Anandhan ,Shelley Herbrich ,Sangeeta Goswami ,Baoxiang Guan ,Yulong Chen ,Marc Daniel Macaluso ,Sonali Jindal ,Seanu Meena Natarajan ,Samuel W Andrewes ,Liangwen Xiong ,Ashwat Nagarajan ,Sreyashi Basu ,Derek Ng Tang ,Jielin Liu ,Jimin Min ,Anirban Maitra ,Padmanee Sharma

Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer

晚期转移性癌症患者对纳武利尤单抗联合伊匹木单抗治疗的反应和耐药的免疫学特征

Apostolia M Tsimberidou # ,Farah A Alayli # ,Kwame Okrah # ,Alexandra Drakaki ,Danny N Khalil ,Shivaani Kummar ,Saad A Khan ,F Stephen Hodi ,David Y Oh ,Christopher R Cabanski ,Shikha Gautam ,Stefanie L Meier ,Meelad Amouzgar ,Shannon M Pfeiffer ,Robin Kageyama ,EnJun Yang ,Marko Spasic ,Michael T Tetzlaff ,Wai Chin Foo ,Travis J Hollmann ,Yanyun Li ,Matthew Adamow ,Phillip Wong ,Jonni S Moore ,Sharlene Velichko ,Richard O Chen ,Dinesh Kumar ,Samantha Bucktrout ,Ramy Ibrahim ,Ute Dugan ,Lisa Salvador ,Vanessa M Hubbard-Lucey ,Jill O'Donnell-Tormey ,Sandra Santulli-Marotto ,Lisa H Butterfield ,Diane M Da Silva ,Justin Fairchild ,Theresa M LaVallee ,Lacey J Padrón ,Padmanee Sharma

Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer

激素受体阳性、HER2 阴性 II-III 期乳腺癌患者术前接受 Durvalumab 和 tremelimumab 治疗

Haven R Garber, Sreyashi Basu, Sonali Jindal, Zhong He, Khoi Chu, Akshara Singareeka Raghavendra, Clinton Yam, Lumarie Santiago, Beatriz E Adrada, Padmanee Sharma, Elizabeth A Mittendorf, Jennifer K Litton

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

新辅助化疗联合纳武利尤单抗(加或不加伊匹木单抗)治疗可手术切除的非小细胞肺癌:NEOSTAR II期平台试验

Tina Cascone ,Cheuk H Leung ,Annikka Weissferdt ,Apar Pataer ,Brett W Carter ,Myrna C B Godoy ,Hope Feldman ,William N William Jr ,Yuanxin Xi ,Sreyashi Basu ,Jing Jing Sun ,Shalini S Yadav ,Frank R Rojas Alvarez ,Younghee Lee ,Aditya K Mishra ,Lili Chen ,Monika Pradhan ,Haiping Guo ,Ansam Sinjab ,Nicolas Zhou ,Marcelo V Negrao ,Xiuning Le ,Carl M Gay ,Anne S Tsao ,Lauren Averett Byers ,Mehmet Altan ,Bonnie S Glisson ,Frank V Fossella ,Yasir Y Elamin ,George Blumenschein Jr ,Jianjun Zhang ,Ferdinandos Skoulidis ,Jia Wu ,Reza J Mehran ,David C Rice ,Garrett L Walsh ,Wayne L Hofstetter ,Ravi Rajaram ,Mara B Antonoff ,Junya Fujimoto ,Luisa M Solis ,Edwin R Parra ,Cara Haymaker ,Ignacio I Wistuba ,Stephen G Swisher ,Ara A Vaporciyan ,Heather Y Lin ,Jing Wang ,Don L Gibbons ,J Jack Lee ,Nadim J Ajami ,Jennifer A Wargo ,James P Allison ,Padmanee Sharma ,Humam Kadara ,John V Heymach # ,Boris Sepesi #

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

新辅助化疗联合纳武利尤单抗(加或不加伊匹木单抗)治疗可手术切除的非小细胞肺癌:NEOSTAR II期平台试验

Tina Cascone,Cheuk H Leung,Annikka Weissferdt,Apar Pataer,Brett W Carter,Myrna C B Godoy,Hope Feldman,William N William Jr,Yuanxin Xi,Sreyashi Basu,Jing Jing Sun,Shalini S Yadav,Frank R Rojas Alvarez,Younghee Lee,Aditya K Mishra,Lili Chen,Monika Pradhan,Haiping Guo,Ansam Sinjab,Nicolas Zhou,Marcelo V Negrao,Xiuning Le,Carl M Gay,Anne S Tsao,Lauren Averett Byers,Mehmet Altan,Bonnie S Glisson,Frank V Fossella,Yasir Y Elamin,George Blumenschein Jr,Jianjun Zhang,Ferdinandos Skoulidis,Jia Wu,Reza J Mehran,David C Rice,Garrett L Walsh,Wayne L Hofstetter,Ravi Rajaram,Mara B Antonoff,Junya Fujimoto,Luisa M Solis,Edwin R Parra,Cara Haymaker,Ignacio I Wistuba,Stephen G Swisher,Ara A Vaporciyan,Heather Y Lin,Jing Wang,Don L Gibbons,J Jack Lee,Nadim J Ajami,Jennifer A Wargo,James P Allison,Padmanee Sharma ,Humam Kadara,John V Heymach #,Boris Sepesi #